/PRNewswire/ The fiducial markers market size is expected to grow by USD 36.5 million from 2021 to 2026. In addition, the growth momentum of the market will.
Share this article
Share this article
ResearchAndMarkets.com s offering.
Amid the COVID-19 crisis, the global market for Fiducial Markers estimated at US$95.7 Million in the year 2020, is projected to reach a revised size of US$129.3 Million by 2027, growing at a CAGR of 4.4% over the analysis period 2020-2027.
Metal, one of the segments analyzed in the report, is projected to record a 5.1% CAGR and reach US$58 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Polymer segment is readjusted to a revised 4% CAGR for the next 7-year period.
The Worldwide Intraoperative Radiation Therapy Industry is Expected to Reach $66 Million by 2025
News provided by
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global intraoperative radiation therapy market is projected to reach USD 66 million by 2025 from USD 48 million in 2020, at a CAGR of 6.4% during the forecast period.
The rising incidence of cancer, technological advancements, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global intraoperative radiation therapy market. Additionally, growing clinical trials exploring the use of IORT for various cancer applications are expected to offer lucrative growth opportunities to market players. However, the complex nature of technology coupled with a shortage of trained personnel and preference of conventional radiotherapy over IORT by physicians owing to reimbursement coverage are the major factors that are expected to restrain the gro
The technological advancements such as the introduction of mobile IORT system, rising incidence of cancer, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global intraoperative radiation therapy products market. Additionally, growing clinical trials exploring the use of IORT for various cancer applications is expected to offer lucrative growth opportunities to market players.
The Electron IORT segment to account for the largest share of the intraoperative radiation therapy market, by technology, in 2019
Based on technology, the intraoperative radiation therapy market is segmented into electron IORT and intraoperative brachytherapy. The electron IORT segment is expected to account for the largest share of the market in 2019. IOERT is a suitable option for patients with locally advanced or recurrent cancer such as partial breast and rectal cancer. Thus, rising target patient population, promising clinical trials, and gro